SCHEDULE OF WARRANT ACTIVITY (Details) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Equity [Abstract] | |
| Warrants, Outstanding, Beginning balance | shares | 87,200 |
| Weighted Average Excerise Price, Outstanding, Beginning balance | $ / shares | $ 36.00 |
| Warrants, Issued | shares | 9,555,155 |
| Weighted Average Excerise Price, Issued | $ / shares | $ 6.90 |
| Warrants, Excercised | shares | (200,000) |
| Weighted Average Excerise Price, Excercised | $ / shares | $ 0.005 |
| Warrants, Expired and cancelled | shares | |
| Weighted Average Excerise Price, Expired and cancelled | $ / shares | |
| Warrants, Unvested shares | shares | 9,442,355 |
| Weighted Average Excerise Price, Unvested shares | $ / shares | $ 7.31 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option exercises in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option forfeiture in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|